Manveen Saluja Md v. Honigman Miller Schwartz and Cohn LLP

CourtMichigan Court of Appeals
DecidedMarch 16, 2017
Docket330367
StatusUnpublished

This text of Manveen Saluja Md v. Honigman Miller Schwartz and Cohn LLP (Manveen Saluja Md v. Honigman Miller Schwartz and Cohn LLP) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Manveen Saluja Md v. Honigman Miller Schwartz and Cohn LLP, (Mich. Ct. App. 2017).

Opinion

STATE OF MICHIGAN

COURT OF APPEALS

MANVEEN SALUJA, M.D., UNPUBLISHED March 16, 2017 Plaintiff/Counter Defendant- Appellant,

v No. 330367 Wayne Circuit Court HONIGMAN MILLER SCHWARTZ AND LC No. 14-003867-NM COHN LLP,

Defendant/Counter Plaintiff- Appellee,

and

LINDA ROSS and ANGELA SPRECHER,

Defendants/Appellees.

Before: HOEKSTRA, P.J., and JANSEN and SAAD, JJ.

PER CURIAM.

In this legal malpractice case, plaintiff appeals the trial court’s order that granted defendants’ motion for summary disposition. For the reasons provided below, we affirm.

I. BASIC FACTS

Plaintiff is a medical doctor who specializes in the field of rheumatology, whose colleague, Dr. G. Krishna Kumar, asked her to advise on medical treatment for Dr. Kumar’s mother, Hamsa Vathy, an elderly woman who lived in India. Plaintiff testified that from 2004 to 2010,1 she wrote prescriptions for fentanyl, a schedule II controlled substance, for Vathy. Plaintiff understood that, while she would write the prescriptions, Dr. Kumar would then fill the prescriptions and carry the drugs to India to give to his mother. Plaintiff estimated that she prescribed approximately 285 patches of fentanyl over that six-year period for Vathy.

1 Vathy died in 2010 at the age of 94.

-1- On the morning of March 28, 2012, plaintiff’s staff called and notified her that DEA agents were at the office to investigate. Plaintiff then called defendant law firm Honigman Miller Schwartz and Cohn LLP (Honigman) and asked to speak to attorney defendant Linda Ross. Plaintiff was informed that Ross was unavailable, and the call concluded. Plaintiff called back and asked to speak with any lawyer. Plaintiff was then routed to speak with attorney defendant Angela Sprecher.

Plaintiff informed Sprecher that DEA agents were present at her office and that she did not know what to do. Upon arrival, plaintiff continued to speak with Sprecher and asked if the DEA agents would speak to her lawyer. After handing the phone over, the agent and Sprecher talked for several minutes, and the agent gave the phone back to plaintiff, where upon Sprecher then told plaintiff to “go ahead with it,” meaning to comply with the agents’ investigation. At that point, the phone conversation with Sprecher ended.

The DEA agents then requested to see the file pertaining to Vathy. After plaintiff produced the file for the agents, agent Sandra White-Hope allegedly, in an intimidating manner, stated that there was a fine of $5,000 per prescription plus jail time for the offenses. Then, according to plaintiff, agent White-Hope handed plaintiff a form and said, “sign it or you’re going to jail.” At this point, plaintiff did not call anyone for advice and, instead, simply signed the form. The form was a “voluntary surrender of controlled substances privileges” form where plaintiff voluntarily surrendered her DEA Certificate of Registration.

A few days later, the DEA offered to reinstate plaintiff’s controlled substances privileges, except for schedule II and II-N privileges, which would remain restricted for a period of three years. Then, plaintiff and her new team of lawyers, led by Christine Derdarian, were able to negotiate the restricted period down to two years. But plaintiff, not fully satisfied, went over the local DEA office’s “head” and contacted the DEA office in Washington, D.C. When the local office learned of this attempt, the two-year offer to plaintiff was withdrawn. Derdarian, however, ultimately was able to convince the local branch to honor the original three-year restriction deal.

Plaintiff filed suit and alleged legal malpractice against all defendants. Plaintiff claimed, inter alia, that defendants should have advised her that she was not required to sit for the DEA interview on the morning of March 28, 2012, and that she should not sign a voluntary release of her DEA privileges.

Defendants moved for summary disposition under MCR 2.116(C)(10) and attacked plaintiff’s ability to prove the essential element of causation. Simply put, defendants argued that plaintiff cannot show how anything would have been different for plaintiff if she had received purportedly “perfect” advice. Plaintiff responded that causation was “direct and clear.” Plaintiff relied on the testimony of attorney Eli Stutsman, who stated that, had defendants acted properly, there was “a good chance” that plaintiff would not have lost her DEA registration. In a reply brief, defendants asserted that plaintiff’s position was nothing more than speculation. Indeed, defendants pointed to Dr. Kumar’s situation as proof that, had plaintiff not surrendered her DEA registration, she still would have lost her privileges. Defendants noted that Dr. Kumar did not initially surrender his privileges but nonetheless ultimately received a deal similar to what plaintiff received—a restricted license for three years. Defendants also highlighted the testimony

-2- of one of plaintiff’s standard-of-care experts, Steven Fishman, who testified that it would have been speculation to opine on whether plaintiff would have received a better deal than the one she received had Sprecher instructed her to not cooperate with the DEA agents.

The trial court granted defendants’ motion. The court found that plaintiff failed to offer any evidence to show how any result would have been different had Honigman or Sprecher given different advice. The court noted that Stutsman’s testimony was inadequate to show that an outcome would have been different because (1) he admitted that he could not specifically say what the outcome would have been had plaintiff not surrendered her DEA registration on March 28, 2012, and (2) under Pontiac Sch Dist v Miller, Canfield, Paddock & Stone, 221 Mich App 602; 563 NW2d 693 (1997), such expert testimony amounts to speculation and is inadequate to prove how the DEA would have acted had plaintiff not surrendered her registration.

II. STANDARD OF REVIEW

We review a trial court’s decision on a motion for summary disposition de novo. Maiden v Rozwood, 461 Mich 109, 118; 597 NW2d 817 (1999). Under MCR 2.116(C)(10), a “court considers affidavits, pleadings, depositions, admissions, and other evidence submitted by the parties” in the light most favorable to the nonmoving party. Id. at 120. The motion is properly granted if “there is no genuine issue of material fact and the moving party is entitled to judgment as a matter of law.” Anzaldua v Neogen Corp, 292 Mich App 626, 630; 808 NW2d 804 (2011).

III. ANALYSIS

In order to succeed on a claim of legal malpractice, a plaintiff must prove the following elements:

(1) the existence of an attorney-client relationship;

(2) negligence in the legal representation of the plaintiff;

(3) that the negligence was a proximate cause of an injury; and

(4) the fact and extent of the injury alleged.

[Bowden v Gannaway, 310 Mich App 499, 503; 871 NW2d 893 (2015) (quotation marks and citation omitted).]

In their motion for summary disposition, defendants claimed that summary disposition was proper because plaintiff was unable to prove the necessary third element of causation.

In presenting a motion for summary disposition, the moving party has the initial burden of supporting its position by affidavits, depositions, or other documentary evidence. The burden then shifts to the opposing party to establish that a genuine issue of disputed fact exists. Where the burden of proof at trial on a dispositive issue rests with the nonmoving party, the nonmoving party may not rely on mere allegations or denials in pleadings, but must go beyond the pleadings to set forth specific facts showing that a genuine issue of material fact exists. If

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Maiden v. Rozwood
597 N.W.2d 817 (Michigan Supreme Court, 1999)
Quinto v. Cross and Peters Co.
547 N.W.2d 314 (Michigan Supreme Court, 1996)
Skinner v. Square D Co.
516 N.W.2d 475 (Michigan Supreme Court, 1994)
Pontiac School District v. Miller, Canfield, Paddock & Stone
563 N.W.2d 693 (Michigan Court of Appeals, 1997)
Charles Reinhart Co. v. Winiemko
513 N.W.2d 773 (Michigan Supreme Court, 1994)
People v. Munn
499 N.W.2d 459 (Michigan Court of Appeals, 1993)
Bowden v. Gannaway
871 N.W.2d 893 (Michigan Court of Appeals, 2015)
Anzaldua v. Neogen Corp.
808 N.W.2d 804 (Michigan Court of Appeals, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Manveen Saluja Md v. Honigman Miller Schwartz and Cohn LLP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/manveen-saluja-md-v-honigman-miller-schwartz-and-cohn-llp-michctapp-2017.